Linking Late Endosomal Cholesterol with Cancer Progression and Anticancer Drug Resistance.

Nguyen MKL, Jose J, Wahba M, Bernaus-Esqué M, Hoy AJ, Enrich C, Rentero C, Grewal T

Open source

DOI
10.3390/ijms23137206
Published
2022 Jun 29
Container
International journal of molecular sciences
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ijms23137206,
  title = {Linking Late Endosomal Cholesterol with Cancer Progression and Anticancer Drug Resistance.},
  author = {Nguyen MKL and Jose J and Wahba M and Bernaus-Esqué M and Hoy AJ and Enrich C and Rentero C and Grewal T},
  year = {2022},
  journal = {International journal of molecular sciences},
  doi = {10.3390/ijms23137206},
  url = {https://doi.org/10.3390/ijms23137206}
}

RIS

TY  - JOUR
TI  - Linking Late Endosomal Cholesterol with Cancer Progression and Anticancer Drug Resistance.
AU  - Nguyen MKL
AU  - Jose J
AU  - Wahba M
AU  - Bernaus-Esqué M
AU  - Hoy AJ
AU  - Enrich C
AU  - Rentero C
AU  - Grewal T
PY  - 2022
JO  - International journal of molecular sciences
DO  - 10.3390/ijms23137206
UR  - https://doi.org/10.3390/ijms23137206
ER  - 

APA

MKL, N., J, J., M, W., M, B., AJ, H., C, E., C, R., & T, G. (2022). Linking Late Endosomal Cholesterol with Cancer Progression and Anticancer Drug Resistance.. International journal of molecular sciences. https://doi.org/10.3390/ijms23137206

Source records